Author

Darby S. Madonick

EFFICACY ANALYSIS OF TRADIPITANT IN IDIOPATHIC AND DIABETIC GASTROPARESIS IN STUDY VP-VLY-686-3301
EFFICACY ANALYSIS OF TRADIPITANT IN IDIOPATHIC AND DIABETIC GASTROPARESIS IN STUDY VP-VLY-686-3301

Darby S. Madonick  et al.

TRADIPITANT, A NOVEL NEUROKININ-1 RECEPTOR ANTAGONIST, SHOWED CONTINUED IMPROVEMENT IN NAUSEA AND OTHER SYMPTOMS ASSOCIATED WITH GASTROPARESIS IN AN OPEN-LABEL EXTENSION OF A PHASE II CLINICAL TRIAL
TRADIPITANT, A NOVEL NEUROKININ-1 RECEPTOR ANTAGONIST, SHOWED CONTINUED IMPROVEMENT IN NAUSEA AND OTHER SYMPTOMS ASSOCIATED WITH GASTROPARESIS IN AN OPEN-LABEL EXTENSION OF A PHASE II CLINICAL TRIAL

Darby S. Madonick  et al.

Item 1 - 2 / 2
1